Status:
COMPLETED
Prediction of Thrombosis Using D-dimer Trends in COVID-19
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
A high incidence of venous thromboembolic events (VTE) has been demonstrated in COVID-19. This incidence correlates with disease severity. Activation of coagulation secondary to sepsis combined with c...
Detailed Description
Primary outcome : Characterize different D-dimer trends in COVID-19 patients. Secondary outcomes : * Identify the predictive value of different D-dimers trends for thrombosis / all-cause mortality /...
Eligibility Criteria
Inclusion
- Inclusion Criteria: Positive SARS-CoV-2 PCR and at least one D-dimer result
- Non inclusion Criteria: Below 18 yo
Exclusion
Key Trial Info
Start Date :
March 2 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 11 2020
Estimated Enrollment :
280 Patients enrolled
Trial Details
Trial ID
NCT04827160
Start Date
March 2 2020
End Date
August 11 2020
Last Update
April 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU Nancy
Nancy, France, 54000